Haematology Journal Articles and Videos
Sickle Cell Trait and Renal Disease
Oncology & Hematology Review, 2016;12(2):95–6 DOI: https://doi.org/10.17925/OHR.2016.12.02.95
Elevated Coagulation Factor IX and Risk of Thrombosis Development
Oncology & Hematology Review, 2016;12(1):15–9 DOI: http://doi.org/10.17925/OHR.2016.12.01.15
Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in 2014—Current Knowledge and Outcomes with Plasma...
Oncology & Hematology Review, 2014;10(2):82–9 DOI: http://doi.org/10.17925/OHR.2014.10.2.82
Iron Deficiency Anemia in Cancer Patients
Oncology & Hematology Review (US), 2012;8(2):74-80 DOI: http://doi.org/10.17925/OHR.2012.08.2.74
Guest professor and senior consultant at the Center for Thrombosis and Hemostasis at the University Medical Center, Mainz, Germany.
Bernhard Lämmle, M.D., was Professor of Hematology and Director of the Department of Hematology and the Central Hematology Laboratory at the University Hospital of Bern, Switzerland, from 1989 until his retirement in July 2013. He then became a guest professor and senior consultant at the Center for Thrombosis and Hemostasis at the University Medical Center, Mainz, Germany. His scientific interest concerns various clinical and laboratory aspects of hematology, hemostasis and thrombosis with a special focus on thrombotic thrombocytopenic purpura and the metalloprotease ADAMTS13. Bernhard Lämmle has coauthored more than 270 publications and held many educational and state-of-the-art lectures at international congresses.